WO2004066856A1 - 超音波プローブ及び超音波装置 - Google Patents
超音波プローブ及び超音波装置 Download PDFInfo
- Publication number
- WO2004066856A1 WO2004066856A1 PCT/JP2004/000812 JP2004000812W WO2004066856A1 WO 2004066856 A1 WO2004066856 A1 WO 2004066856A1 JP 2004000812 W JP2004000812 W JP 2004000812W WO 2004066856 A1 WO2004066856 A1 WO 2004066856A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ultrasonic
- therapeutic
- wave
- diagnostic
- transducer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/54—Control of the diagnostic device
- A61B8/546—Control of the diagnostic device involving monitoring or regulation of device temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0808—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of the brain
- A61B8/0816—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of the brain using echo-encephalography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/481—Diagnostic techniques involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
Definitions
- the present invention relates to an ultrasonic probe and an ultrasonic device for performing ultrasonic treatment.
- Ultrasound equipment emits diagnostic ultrasound through a diagnostic probe that has been brought into contact with the body surface of the subject, and based on reflected echo signals generated from the subject, generates ultrasound images (for example,
- the treatment site is non-invasively treated by emitting treatment ultrasonic waves to the subject via the treatment probe.
- a diagnostic probe and a therapeutic probe are arranged side by side on the body of the subject and contacted to emit therapeutic ultrasonic waves while confirming the treatment site with an ultrasonic image.
- a diagnostic probe and a therapeutic probe are arranged side by side on the body of the subject and contacted to emit therapeutic ultrasonic waves while confirming the treatment site with an ultrasonic image.
- an ultrasonic probe according to the present invention includes a plurality of first transducers arranged, a treatment transducer that emits treatment ultrasound to a subject, and a plurality of the arranged transducers.
- a diagnostic vibrator that emits diagnostic ultrasonic waves to the subject and receives the diagnostic ultrasonic waves reflected by the subject.
- the diagnostic transducer is laminated with the diagnostic transducer.
- the control accuracy of the irradiation position of the therapeutic ultrasonic wave can be reduced. Can be improved.
- the center of the diameter of the therapeutic oscillator and the center of the diameter of the diagnostic oscillator can be matched.
- the ultrasonic apparatus includes: the ultrasonic probe; a therapeutic transmitting unit that generates a driving signal of the therapeutic vibrator; and a diagnostic transmitting unit that generates a drive signal of the diagnostic vibrator.
- a detecting unit, wherein the therapeutic wave transmitting unit has a warning function of outputting warning information based on the state of the treatment detected by the detecting unit.
- the present invention it is possible to detect the progress of treatment by treatment ultrasonic waves and the like, so that the operator can sound a warning sound or display a warning message when treatment is completed, so that the operator can The ultrasonic treatment can be stopped, and the usability of the ultrasonic device is improved. In addition, it is possible to prevent the treatment ultrasonic wave from being excessively irradiated to the treatment site.
- FIG. 1 is a configuration diagram of an ultrasonic apparatus according to a first embodiment of the present invention
- FIG. 2 is a perspective view schematically showing the ultrasonic probe according to the first embodiment of the present invention
- FIG. 3 is a cross-sectional view taken along line II-II of FIG.
- FIG. 4 is a perspective view schematically showing an ultrasonic probe according to another embodiment
- FIG. 5 is a time chart showing the operation of the ultrasonic probe
- FIG. 6 is a configuration diagram of an ultrasonic apparatus according to a second embodiment of the present invention
- FIG. 7 is a configuration diagram of an ultrasonic device according to a third embodiment of the present invention
- FIG. 8 is a configuration diagram of an ultrasonic device according to a fourth embodiment of the present invention.
- FIG. 9 is a perspective view schematically illustrating an ultrasonic probe according to a fifth embodiment of the present invention.
- FIG. 10 is a schematic view illustrating another example of the ultrasonic probe according to the fifth embodiment of the present invention.
- FIG. 11 is a perspective view schematically showing still another example of the ultrasonic probe according to the fifth embodiment of the present invention.
- FIG. 12 is a configuration diagram of a therapeutic ultrasonic wave transmission unit according to a seventh embodiment of the present invention
- FIG. 13 is a diagram illustrating avoidance of interference between an incident wave and a reflected wave in the eighth embodiment of the present invention
- the present embodiment is an example of an ultrasonic probe in which a plurality of diagnostic transducers are stacked on an ultrasonic emission surface of a treatment transducer.
- the ultrasonic device 1 includes a diagnostic ultrasonic unit 9, a therapeutic ultrasonic transmitting unit 24, a display unit 18, an input unit 20, a control unit 21 and the like.
- the diagnostic ultrasonic unit 9 includes a diagnostic transmitting / receiving section 12 having a diagnostic transmitting section, and an image forming section including a tomographic image forming section 14 and a blood flow image forming section 16.
- the therapeutic ultrasound transmitting unit 24 includes a therapeutic transmitting unit 25, an alarm unit 27, and the like.
- the diagnostic transmitting / receiving section 12 and the therapeutic transmitting section 25 are connected to an ultrasonic probe 10.
- the diagnostic transmitting / receiving section 12 generates a drive signal for transmitting the diagnostic ultrasonic wave to the ultrasonic probe 10 and receives a reflected echo signal output from the ultrasonic probe 10. is there.
- the tomographic image forming unit 14 reconstructs a tomographic image based on the reflected echo signal.
- the blood flow image forming section 16 obtains a blood flow velocity from the Doppler deviation of the reflected echo signal to reconstruct a blood flow image.
- the therapeutic wave transmitting section 25 is a drive signal for causing the ultrasonic probe 10 to emit therapeutic ultrasonic waves. No. is generated.
- the alarm unit 27 has a warning function of sounding a buzzer or displaying a warning message according to an input command.
- the display unit 18 displays a tomographic image and a blood flow image on a display screen of a monitor.
- the input unit 20 has a pointing device such as a keyboard and a mouse.
- the ultrasonic probe 10 emits ultrasonic waves for diagnosis and treatment, and is included in the headset 11.
- the head set 11 includes an ultrasonic probe 10, a probe cooling unit including water bags 32 a and 32 b, a circulation path 36, and a heat radiating unit 34.
- the water bags 32a and 32b are formed in a bag shape, and a cooling medium (for example, water) is stored therein.
- the water bags 32a and 32b are not limited to bags.
- the circulation path 36 guides the water in the water bags 32 a and 32 b to the radiator 34.
- the radiator 34 radiates the heat of the guided water to the outside air.
- the head set 11 is attached to the head of the subject.
- the water bags 32a and 32b of the headset 11 are fixed in contact with the epidermis of the subject's head (for example, near the temple).
- the ultrasonic probe 10 is brought into contact with the back surface of the water bag 32a.
- a drive signal is supplied to the ultrasonic probe 10 from the transmitting / receiving section 12 for diagnosis.
- Ultrasonic waves for diagnosis are emitted from the ultrasonic probe 10 toward the subject by the supplied drive signal.
- the emitted diagnostic ultrasonic waves are reflected or scattered by living tissue or blood flow in the head.
- the diagnostic ultrasonic wave is received by the ultrasonic probe 10 as a reflected echo signal.
- the received reflected echo signal is reconstructed as a tomographic image by the tomographic image forming unit 14.
- the reconstructed tomographic image is displayed on the monitor of the display unit 18. By observing the displayed tomographic image, the position of the treatment site (for example, cerebral thrombus) can be accurately specified.
- the position of the treatment site (for example, cerebral thrombus) on the tomographic image is input and set from the input unit 20. Based on the set position coordinates of the cerebral thrombus, a drive signal is generated by the therapeutic wave transmitting unit 25. The generated drive signal is supplied to the therapeutic wave transmitter 25 of the ultrasonic probe 10. With this, the ultrasonic probe 10 irradiates therapeutic ultrasonic waves to the cerebral thrombus, Dissolve cerebral thrombus non-invasively.
- a blood flow image (for example, a two-dimensional Doppler blood flow image, a pulsed Doppler FFT measurement image) is reconstructed and displayed based on the obtained Doppler stitches.
- both probes are arranged side by side and contact the water bag 32a.
- a difference occurs in the scanning coordinates between the diagnostic ultrasonic wave and the therapeutic ultrasonic wave according to the difference in the contact position between the two probes.
- the ultrasonic probe 10 is configured by laminating a diagnostic transducer 52, a therapeutic transducer 50, a backing material 54, and a cooling unit 56 in order from the subject side. ing.
- the therapeutic transducer 50 generates ultrasonic waves of relatively low frequency (for example, about 500 kHz)
- the diagnostic transducer 52 generates ultrasonic waves of relatively high frequency (for example, about 2 MHz). Generate. Therefore, the ultrasonic wave generated from the diagnostic oscillator 52 is more difficult to penetrate an obstacle than the ultrasonic wave generated from the therapeutic oscillator 50, and the diagnostic oscillator 52 is closer to the specimen. As shown in FIG.
- the therapeutic vibrator 50 is formed by arranging a plurality of vibrating elements 50a to 50d.
- Each of the treatment vibration elements 50a to 50d is formed of a rectangular parallelepiped piezoelectric ceramic, and is disposed at equal intervals with the longitudinal direction of the ultrasonic emission surface 51 being parallel.
- the disposed therapeutic vibrating elements 50a to 50d convert the drive signal from the therapeutic wave transmitting section 24 into mechanical vibrations, and apply the therapeutic signals to the treatment site (for example, cerebral thrombus). Deflected sound waves are emitted.
- the diagnostic vibrator 52 is formed by arranging a plurality of vibrating elements 52 a to 52 p.
- Each of the diagnostic vibrating elements 52 a to 52 p is formed of a rectangular parallelepiped piezoelectric ceramic, and the vibrating elements 50 a to 50 p of the therapeutic vibrator 50 are provided to increase the resolution of the reconstructed tomographic image. It is formed smaller than 0 d.
- the plurality of diagnostic transducers 52 a to 52 p are distributed on the ultrasonic emission surface 51. For example, as shown in FIG. 2, the diagnostic transducers 52a to 52d are distributed on the ultrasonic emission surface 51 of the therapeutic transducer 50a.
- the surfaces of the diagnostic vibrating elements 52 a to 52 d opposite to the ultrasonic wave emitting surface 53 are joined to the ultrasonic wave emitting surface 51 of the therapeutic vibration element 50 a.
- the diagnostic transducers 52a to 52d are arranged at equal intervals in the short direction of the ultrasonic emission surface 51 and with the longitudinal direction of the ultrasonic emission surface 53 parallel. I have. The same applies to the diagnostic vibrating elements 52e to 52p.
- Each of the arranged diagnostic transducers 52a to 52p converts, for example, a pulse-like electric signal from the transmitting / receiving section 12 into mechanical vibration and deflects and transmits diagnostic ultrasonic waves to the subject.
- the packing material 54 is formed of a low-impedance layer or the like having a thickness of half the wavelength of the therapeutic ultrasonic wave, and is opposite to the ultrasonic emission surface 51 of the therapeutic vibration elements 50a to 50d. It is provided on the side surface.
- the cooling unit 56 is provided so as to overlap with the back surface of the backing material 54, that is, on the side opposite to the ultrasonic wave emitting direction of the therapeutic transducer 50.
- the cooling section 56 is formed of a Peltier element or the like, and when current flows, absorbs heat by the Peltier effect and radiates heat to the outside air. Thereby, the temperature rise of the ultrasonic probe 10 can be suppressed.
- the therapeutic transducer elements 5 0 a ⁇ 5 0 d thickness, the diagnostic transducer elements 5 2 a ⁇ 5 2 p thick t 2, the therapeutic transducer elements 5 0 a ⁇ 5 0 d array pitch, And the array pitch P2 of the diagnostic vibrating elements 52a to 52p is set to be close to the value calculated by the following equations (1) to (4): (l)
- fx is the frequency of the therapeutic ultrasound emitted from the therapeutic transducer 50
- 2 is the frequency of the diagnostic ultrasound emitted from the diagnostic transducer 52
- a 2 is The wavelength of the diagnostic ultrasonic wave
- c is the longitudinal sound velocity in the thickness direction of the therapeutic transducer 50, that is, the ultrasonic wave emitting direction, and is the sound velocity in water or a living body.
- the frequency / i is 500 kHz, and the frequency / 2 is 2 MHz. But was, connexion, the sound velocity c 3. 3 mm / S, the speed of sound cw 1.
- the thickness ti is 3. 3 mm
- array pitch is 1.54mm
- array pitch ⁇ 2 is 0.39mm .
- the ultrasonic probe 10 With such dimensions, for example, even when the opening of the skull is thin and the ultrasonic transmission is relatively good (for example, near the temple) is limited to 30 mm square, for example, the ultrasonic probe 10 The ultrasonic aperture D of this falls within that range. Therefore, it is possible to reduce the loss of the energy of the diagnostic ultrasonic wave and the therapeutic ultrasonic wave due to the thickness of the skull.
- the distance d 2 intervals and diagnostic transducer elements of therapeutic vibrating element as narrow as possible the better.
- the frequency of the ultrasonic wave to be used is determined from the viewpoint of effect and safety. For example, if the limit of the intensity of the therapeutic ultrasound is 720 mW / cm, the temperature rise To be below, the frequency / i is adjusted below 580 kHz. As a result, the value of the thermal index (TI), which is an index indicating the intensity of the thermal action of the ultrasonic wave, can be reduced to 2 or less. Further, the frequency / i is adjusted to more than 390 kHz. This makes it possible to reduce the mechanical index (Ml), which is an index indicating the strength of the mechanical mechanical action of ultrasonic waves that destroy tissue cells due to cavitation or the like generated in blood vessels, to 0.25 or less. it can.
- TI thermal index
- Ml mechanical index
- an ultrasonic probe 10 having four therapeutic vibration elements 50 a to 50 d and 16 diagnostic vibration elements 52 a to 52 p is described.
- the number of each vibrating element can be appropriately changed.
- the phase control method and the circuit type can be simplified.
- a sound insulating material 53 is provided.
- the material of the sound insulating material 53 include fine particles such as tungsten and microballoons dispersed in an epoxy resin.
- the operation of the ultrasonic probe 10 will be described with reference to FIG.
- the treatment ultrasonic waves from the treatment transducer 50 are received by the diagnostic transducer 52 as noise. Therefore, in the present embodiment, as shown in FIG. 5, the therapeutic ultrasonic beam (T beam) and the diagnostic ultrasonic beam (D beam) are alternately emitted at set time intervals. Note that the emission timing of the T beam and the D beam may be appropriately changed so that noise does not occur.
- a D beam for example, a frequency of 2 MHz
- a T beam for example, a frequency of 500 kHz
- the emission time of the D beam is set in the range of, for example, 0.01 to 0.2 second, since it is sufficient that a tomographic image or a two-dimensional blood flow image can be formed.
- the emission time of the T beam is appropriately set, for example, in the range of 1 to 10 seconds.
- the D beam is formed, for example, by transmitting a burst wave in which pulse waveforms are bundled at 1Z2 to 20 wavelengths at set intervals.
- the T beam is formed by transmitting continuously transmitted ultrasonic waves so that a predetermined mechanical index can be secured.
- the control accuracy of the irradiation position of the therapeutic ultrasonic wave can be reduced. Can be improved. Therefore, it is possible to accurately irradiate the T beam to the treatment site whose position is specified by the D beam.
- the ultrasonic probe 10 By electrically controlling the ultrasonic probe 10 without moving it along the body surface, it is possible to reconstruct a tomographic image using a D beam and to treat a treatment site using a T beam. . Therefore, the efficiency of the ultrasonic treatment can be improved, for example, the treatment time can be shortened. For example, when a cerebral infarction develops, it is necessary to dissolve the cerebral thrombus within a short time from the onset, but according to the present embodiment, the cerebral thrombus can be rapidly and accurately dissolved.
- FIG. 6 shows a configuration diagram of the ultrasonic apparatus of the present embodiment.
- a blood flow detection unit 22 is provided.
- the blood flow detection unit '22 detects the intensity of the Dobra deviation signal of the reflected echo signal generated from the treatment site, that is, the blood flow velocity, and the detected blood flow velocity exceeds the set value ( ⁇ ). Output a control command to the transmission unit 24 for therapy.
- the control command is not output to the therapeutic ultrasonic transmission unit 24. Therefore, the therapeutic wave transmitting section 25 maintains or increases the energy (eg, amplitude and frequency) of the therapeutic ultrasonic wave.
- the control command is output to the therapeutic ultrasonic transmission unit 24, and the therapeutic transmission unit 25 outputs Reduce the sound energy or stop the injection.
- a warning sound for example, a buzzer sound or voice
- a warning message is displayed on the display unit 18.
- the present embodiment it is possible to detect that the thrombus has been dissolved and blood has begun to flow. In this way, when blood begins to flow, the amplitude or frequency of the therapeutic ultrasound is reduced or injection is automatically stopped. Therefore, it is possible to prevent the treatment site from being excessively irradiated with the therapeutic ultrasonic waves.
- the therapeutic ultrasound may be manually stopped when a warning sound or a warning message is issued.
- the ultrasonic apparatus of the present embodiment can be used even when the diagnostic probe and the therapeutic probe are separated from each other. Can be applied.
- FIG. 7 shows a configuration diagram of the ultrasonic apparatus of the present embodiment.
- a temperature detecting unit 28 detects the temperature of the ultrasonic probe 10 and outputs a control command to the therapeutic transmission unit 24 when the detected temperature exceeds a set value.
- the control command is not output to the therapeutic ultrasound transmission unit 24. Therefore, the therapeutic wave transmitter 25 maintains or increases the energy (eg, amplitude and frequency) of the therapeutic ultrasonic wave.
- a control command is output to the therapeutic ultrasonic transmitting unit 24, and the therapeutic transmitting unit 25 reduces the energy for treatment or performs injection. Stop. At this time, a warning sound (for example, a single buzzer sound or voice) is issued by the warning unit 27 or a warning message is displayed on the display unit 18.
- a warning sound for example, a single buzzer sound or voice
- the temperature rise of the ultrasonic probe 10 can be automatically suppressed, it is possible to avoid a side effect on the living tissue due to the temperature rise.
- the temperature of the water bag 32a in FIG. 1 may be detected. In short, it suffices to detect the temperature correlated with the therapeutic oscillator 50 or the diagnostic oscillator 52.
- the therapeutic ultrasound may be manually stopped when a warning sound or a warning message is issued.
- the ultrasonic apparatus of the present embodiment can be used even when the diagnostic probe and the therapeutic probe are separated from each other. Can be applied.
- FIG. 8 shows a configuration diagram of the ultrasonic apparatus of the present embodiment.
- a thrombolytic agent that promotes thrombus dissolution is injected into the subject.
- the thrombolytic agent may be injected into the subject even after the thrombus has been dissolved and blood has begun to flow.
- a dissolving agent injection control unit 30 is provided.
- the dissolving agent injection control unit 30 includes an injection control unit 31, a calculation unit 29, an alarm unit 33, and the like.
- the injection controller 31 controls the injection amount of the thrombolytic agent to be injected into the subject via the injector probe 26.
- the calculation unit 29 calculates the injection amount of the thrombolytic agent into the subject based on the control command from the blood flow detection unit 22.
- the alarm unit 33 sounds a warning buzzer or displays a warning message based on a control command from the blood flow detection unit 22.
- the control command is not output to the dissolution agent injection control unit 30. Therefore, the injection control unit 31 maintains or increases the injection amount of the thrombolytic agent.
- a control command is output to the dissolution agent injection control unit 30 and the injection control unit 31 is operated by the arithmetic unit. 29 Reduce the injection of thrombolytic agent or stop the injection operation based on the injection volume calculated in step 9.
- a buzzer sound or a sound is issued by the alarm unit 33, or a warning message is displayed on the display screen of the monitor 18.
- the injection amount of the thrombolytic agent can be automatically reduced or stopped. Therefore, side effects of excessive thrombolytic agent on biological tissues are avoided.
- the injection of the thrombolytic agent may be stopped manually when a warning sound or a warning message is issued. Further, the injection amount of the thrombolytic agent may be displayed on the display screen of the monitor 18 in real time. As a result, the operator can objectively grasp the injection amount of the thrombolytic agent.
- the ultrasonic apparatus of the present embodiment can be used even when the diagnostic probe and the therapeutic probe are separately provided. Can be applied.
- a fifth embodiment to which the ultrasonic probe and the ultrasonic device according to the present invention are applied will be described with reference to FIGS.
- the present embodiment is different from the first embodiment in that the cooling unit is installed on the side of the therapeutic oscillator and the diagnostic oscillator.
- FIG. 9 shows an ultrasonic probe according to the present embodiment.
- the cooling units 56 a and 56 b are provided on two side surfaces of the therapeutic oscillator 50 and the diagnostic oscillator 52, respectively.
- the heat of the ultrasonic probe 10 can be radiated to the outside air by appropriately supplying a current to the cooling units 56a and 56b. Therefore, it is possible to continuously irradiate the treatment site with ultrasonic waves for a relatively long time while suppressing the temperature rise of the ultrasonic probe 10 to a set value (for example, 2 ° C.) or less. As a result, it is possible to improve the treatment efficiency such as shortening the treatment time.
- the cooling unit 56 may be installed at any position as long as the treatment oscillator 50 or the diagnostic oscillator 52 can be cooled.
- a cooling unit 56c may be provided so as to cover a side wall surrounding the periphery of the ultrasonic probe 10.
- a metal foil may be used in addition to the cooling section.
- a metal foil 60 is provided on the ultrasonic wave emitting surface of the diagnostic transducer 52 of FIG. Further, the disposed metal foil 60 comes into contact with the cooling sections 56a and 56b. As a result, the heat generated by the diagnostic oscillator 52 is absorbed by the metal foil 60. The absorbed heat is guided to the cooling units 56 a and 56 b via the metal foil 60.
- the guided heat is radiated by the Peltier effect of the cooling units 56a and 56b. Therefore, the temperature rise of the ultrasonic probe 10 can be suppressed.
- the metal foil 60 is made by thinning a conductor (for example, a metal) by several meters and is made of a material that does not affect the emission of ultrasonic waves.
- the ultrasonic emission surface of the diagnostic transducer 52 is covered by the metal foil 60, when the ultrasonic probe 10 is brought into contact with the body surface, the temperature of the ultrasonic probe 10 is applied to the subject. Do not communicate directly. Therefore, it is possible to prevent the subject from being affected by the temperature of the ultrasonic probe 10.
- the present embodiment is different from the first to fifth embodiments in that a treatment ultrasonic wave of a pulse wave is emitted in order to avoid a side effect occurring in a living tissue.
- a treatment ultrasonic wave of a pulse wave is emitted in order to avoid a side effect occurring in a living tissue.
- the therapeutic ultrasonic wave incident on the brain from the ultrasonic probe 10 may be reflected back on the inner wall of the skull in the traveling direction. This is because the skull has a relatively higher acoustic impedance than the biological tissue in the brain.
- the reflected therapeutic ultrasound overlaps with and interferes with the therapeutic ultrasound (hereinafter, “incident wave”) that enters the brain from the ultrasound probe 10, so that it is standing in the brain. Waves may occur.
- the standing wave has a relatively large intensity (amplitude) locally, it may cause side effects on living tissues in the brain.
- the therapeutic wave transmitting unit 25 generates a drive signal of a burst wave from the basic waveform.
- the generated drive signal is supplied to the treatment oscillator 50, so that a burst wave is emitted from the treatment oscillator 50 to the subject.
- the emission time of the burst wave is set to be relatively short (for example, 10 us), and the pause time is set to be relatively long (for example, 100 s to 300 s).
- a burst wave obtained by bundling a pulse wave having a duration of one wavelength, for example, 2 as is emitted.
- the pause time of the burst wave is set to be longer than 100 s. Note that the burst wave emission time and pause time are appropriately changed and are set in advance from the input unit 20.
- the burst wave T eta burst wave tau eta + 1 it does not overlap, is avoided to cause side effects to the living tissue.
- the therapeutic ultrasound has a frequency of, for example, 500 kHz, so that the attenuation when traveling in the brain is relatively small. Therefore, the intensity of the reflected wave and that of the incident wave are almost equal, and the intensity of the interference wave is relatively large.
- the frequency of the diagnostic ultrasonic wave is generally set to, for example, 2 MHz or more, attenuation during traveling in the brain is relatively large. Therefore, generated Although the intensity of the interference wave is relatively small, the pause time of the pulse wave or the burst wave may be set to be relatively long as in the case of the therapeutic ultrasound.
- the emission time of the burst wave is set to, for example, 10 ns, but may be changed as appropriate. In short, it is sufficient if the incident wave and the reflected wave interfere with each other so long as the duration of the interference wave can be shortened to avoid the side effect of the living tissue.
- the ultrasonic apparatus of the present embodiment can be used even when the diagnostic probe and the therapeutic probe are separately provided. Can be applied.
- FIG. 12 is a configuration diagram of the therapeutic wave transmitting section 25 of FIG.
- the therapeutic transmitter 24 As shown in Fig. 12, the therapeutic transmitter 24, the clock generator 70, the modulation signal generator 72, the phase shift circuit 74a to 74m (m: natural number), the amplifier (hereinafter, the amplifier) 76 a-76 m).
- the phase shift circuits 74a to 74m can also be formed from delay circuits and the like.
- m corresponds to the number of therapeutic vibration elements 50 a to 50 m constituting the ultrasonic probe 10.
- a basic continuous wave is generated by the clock generator 70.
- the generated basic waveform is shifted in phase by the phase shift circuits 74a to 74m.
- each of the fundamental waveforms is amplified by the amplifiers 76a to 76m, and is then input to the therapeutic oscillator 50 as a drive signal.
- the therapeutic ultrasonic wave is emitted from the therapeutic transducer 50 by the input drive signal.
- a modulation signal is generated by the modulation signal generator 72 as the injection time elapses.
- the generated modulation signal is input to each of the phase shift circuits 74a to 74m.
- the phase shift circuits 74a to 74m greatly modulate the frequency of the basic waveform according to the input modulation signal.
- the modulated waveform is input to the therapeutic transducer 50 as a drive signal.
- the therapeutic ultrasonic wave whose frequency is greatly modulated is emitted from the therapeutic vibrator 50.
- f the frequency of the ultrasonic wave when it is started to be emitted
- ⁇ The frequency of the ultrasonic wave of 10 S
- ⁇ The frequency of the ultrasonic wave of 10 S
- the wavelength is ⁇ .
- a modulation signal is generated by the modulation signal generator 72 so that the value becomes 4.
- the therapeutic ultrasonic wave emitted from the therapeutic transducer 50 has a frequency modulated in the time axis direction.
- the frequency of the overlapped reflected wave and the incident wave is different. Therefore, since the interference pattern between the reflected wave and the incident wave is not fixed, the intensity of the interference wave generated by the interference between the reflected wave and the incident wave can be suppressed.
- the time for changing the frequency may be set as appropriate, but in the present embodiment, the emitted ultrasonic wave penetrates from the surface of the brain into the skull so that the interference pattern of the therapeutic ultrasonic wave is not fixed at all.
- the frequency of the therapeutic ultrasound is modulated every time (eg, 10 / is) before it progresses into the brain. In short, the frequency may be modulated in the time axis direction based on the basic waveform.
- the frequency modulation value can be set as appropriate. For example, if the frequency is changed so that the reflected wave and the incident wave are shifted by 1 Z 4 to 1/2 wavelength, the reflected wave and the incident wave interfere so as to cancel each other. Therefore, an increase in the intensity of the interference wave can be further suppressed.
- the ultrasonic apparatus of the present embodiment can be used even when the diagnostic probe and the therapeutic probe are separately provided. Can be applied.
- FIGS. 12 and 13 An eighth embodiment to which the ultrasonic probe and the ultrasonic device according to the present invention are applied will be described with reference to FIGS. 12 and 13.
- the present embodiment is different from the seventh embodiment in that the incident direction of the therapeutic ultrasonic wave is shifted every set time.
- FIG. 13 is an explanatory view showing the principle that the incident wave and the reflected wave of the therapeutic ultrasonic wave do not interfere with each other.
- the preset delay data is added to the phase shift circuits 74 a to 7 every set time (for example, 0.1 second). 4 m each.
- the ultrasonic waves emitted from the therapeutic transducer 50 are deflected. Therefore, the emission direction of the ultrasonic beam changes. Note that the angle (0) at which the emission direction of the ultrasonic beam is changed may be changed as appropriate.
- the traveling direction of the incident wave of the therapeutic ultrasonic wave and the traveling direction of the reflected wave are not on the same straight line.
- the incident wave and the reflected wave have different directions, so that interference between the incident wave and the reflected wave can be avoided.
- the set time for changing the ultrasonic wave emission direction is set to 0.1 second, but may be set as appropriate. For example, if an incident wave and a reflected wave overlap and interfere, the interference wave may generate a caption (bubble) in the blood vessel. The resulting cavitation gradually breaks down after growing larger. The adverse effects of the broken cavitation may cause side effects on living tissues. Therefore, it is desirable to change the ultrasonic wave emitting direction before cavitation occurs.
- the ultrasonic apparatus of the present embodiment can be used even when the diagnostic probe and the therapeutic probe are separately provided. Can be applied.
- the ultrasonic probe and the ultrasonic device of the present invention can be applied to the treatment of myocardial infarction in addition to the treatment of cerebral infarction.
- an ultrasound probe is brought into contact with the chest, and diagnostic and therapeutic ultrasound is emitted from the gap between the ribs of the chest toward the thrombus in the coronary artery of the heart.
- the ultrasonic probe and ultrasonic device of the present invention can also be applied to dissolving abnormal solids (for example, calculi) formed of inorganic substances and salts in the body.
- cerebral infarction includes lacunar infarction, atherothrombotic infarction and cardiogenic cerebral embolism.
- Lacunar infarction is a small infarct in the deep part of the brain caused by the narrow arteries of the brain being damaged by high blood pressure and clogging those arteries.
- Arterial thrombotic infarction is a sclerosis of the large arteries in the cervical or intracranial arteries (atherosclerosis) As a result, the artery becomes narrow, and a thrombus is formed at that position, thereby blocking blood flow.
- a cardiogenic cerebral embolus is one in which a blood clot (thrombus) formed in the heart peels off and flows into the arteries of the brain, causing a blockage in blood flow.
- thrombus blood clot
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Radiology & Medical Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Surgical Instruments (AREA)
- Transducers For Ultrasonic Waves (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005504740A JP4543430B2 (ja) | 2003-01-31 | 2004-01-29 | 超音波プローブ及び超音波装置 |
EP04706363A EP1591073A4 (en) | 2003-01-31 | 2004-01-29 | ULTRASONIC PROBE AND ULTRASONIC DEVICE |
US10/543,916 US7662098B2 (en) | 2003-01-31 | 2004-01-29 | Ultrasonic probe and ultrasonic device |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-024252 | 2003-01-31 | ||
JP2003024252 | 2003-01-31 | ||
JP2003-352464 | 2003-10-10 | ||
JP2003352464 | 2003-10-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004066856A1 true WO2004066856A1 (ja) | 2004-08-12 |
Family
ID=32828927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/000812 WO2004066856A1 (ja) | 2003-01-31 | 2004-01-29 | 超音波プローブ及び超音波装置 |
Country Status (4)
Country | Link |
---|---|
US (1) | US7662098B2 (ja) |
EP (1) | EP1591073A4 (ja) |
JP (1) | JP4543430B2 (ja) |
WO (1) | WO2004066856A1 (ja) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006137484A1 (ja) * | 2005-06-22 | 2006-12-28 | Hitachi Medical Corporation | 超音波治療装置 |
JP2010500084A (ja) * | 2006-08-11 | 2010-01-07 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 脳血流画像化、及びマイクロバブルを用いた血餅溶解をする超音波システム |
JP2010500085A (ja) * | 2006-08-11 | 2010-01-07 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 脳血流撮影及び微細気泡改善血栓消散のための超音波システム |
JP2012509126A (ja) * | 2008-11-19 | 2012-04-19 | インサイテック・リミテッド | 閉ループ血塊溶解 |
JP5222942B2 (ja) * | 2008-05-16 | 2013-06-26 | 株式会社日立メディコ | 超音波診断装置 |
JP5282309B2 (ja) * | 2007-11-26 | 2013-09-04 | コニカミノルタ株式会社 | 超音波探触子および該製造方法ならびに超音波診断装置 |
JP2014523263A (ja) * | 2011-05-20 | 2014-09-11 | ドヘニー アイ インスティテュート | 眼球用超音波プローブ |
JP2015519970A (ja) * | 2012-06-13 | 2015-07-16 | ニューウェル, デイビッド ダブリュー.NEWELL, David, W. | 超音波血栓溶解療法を用いたクモ膜下血腫の治療、並びに関連する装置、システム、及び方法 |
US9177543B2 (en) | 2009-08-26 | 2015-11-03 | Insightec Ltd. | Asymmetric ultrasound phased-array transducer for dynamic beam steering to ablate tissues in MRI |
JP5892639B1 (ja) * | 2015-03-06 | 2016-03-23 | 株式会社Murakumo | 超音波発振装置 |
US9412357B2 (en) | 2009-10-14 | 2016-08-09 | Insightec Ltd. | Mapping ultrasound transducers |
US9852727B2 (en) | 2010-04-28 | 2017-12-26 | Insightec, Ltd. | Multi-segment ultrasound transducers |
JP2019524294A (ja) * | 2016-08-01 | 2019-09-05 | コーダンス メディカル インコーポレイテッドCordance Medical Inc. | 血液脳関門の超音波ガイド下開放 |
EP1912749B1 (en) * | 2005-07-26 | 2021-04-21 | Surf Technology AS | Dual frequency band ultrasound transducer arrays |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6618620B1 (en) | 2000-11-28 | 2003-09-09 | Txsonics Ltd. | Apparatus for controlling thermal dosing in an thermal treatment system |
JP4492818B2 (ja) * | 2004-06-21 | 2010-06-30 | 博 古幡 | 超音波脳梗塞治療装置 |
JP2006020710A (ja) * | 2004-07-06 | 2006-01-26 | Ge Medical Systems Global Technology Co Llc | 超音波撮影装置 |
US8409099B2 (en) | 2004-08-26 | 2013-04-02 | Insightec Ltd. | Focused ultrasound system for surrounding a body tissue mass and treatment method |
US20070129652A1 (en) * | 2005-11-15 | 2007-06-07 | Henry Nita | Methods and apparatus for intracranial ultrasound therapies |
US8012092B2 (en) | 2005-08-30 | 2011-09-06 | Koninklijke Philips Electronics N.V. | Method of using a combination imaging and therapy transducer to dissolve blood clots |
US10219815B2 (en) | 2005-09-22 | 2019-03-05 | The Regents Of The University Of Michigan | Histotripsy for thrombolysis |
US9492686B2 (en) * | 2006-12-04 | 2016-11-15 | Koninklijke Philips N.V. | Devices and methods for treatment of skin conditions |
US20080229832A1 (en) * | 2007-02-16 | 2008-09-25 | Los Alamos National Security | Automatic time-of-flight selection for ultrasound tomography |
WO2008132835A1 (ja) * | 2007-04-24 | 2008-11-06 | Panasonic Corporation | 超音波診断装置 |
US20080284578A1 (en) * | 2007-05-16 | 2008-11-20 | Evdokimos Mouratidis | Automobile communication device |
WO2009021535A1 (en) * | 2007-08-14 | 2009-02-19 | Campus Micro Technologies Gmbh | Medical devices, systems and methods for blood pressure regulation |
US9717896B2 (en) | 2007-12-18 | 2017-08-01 | Gearbox, Llc | Treatment indications informed by a priori implant information |
US8636670B2 (en) | 2008-05-13 | 2014-01-28 | The Invention Science Fund I, Llc | Circulatory monitoring systems and methods |
US20090292212A1 (en) * | 2008-05-20 | 2009-11-26 | Searete Llc, A Limited Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US9672471B2 (en) | 2007-12-18 | 2017-06-06 | Gearbox Llc | Systems, devices, and methods for detecting occlusions in a biological subject including spectral learning |
US20090287191A1 (en) * | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US20090287120A1 (en) | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
CN105126262B (zh) | 2008-07-14 | 2019-03-22 | 代理并代表亚利桑那州立大学的亚利桑那董事会 | 使用超声用于调节细胞活性的方法和装置 |
WO2010103469A1 (en) * | 2009-03-12 | 2010-09-16 | Koninklijke Philips Electronics, N.V. | Sonolysis of blood clots using low power, coded excitation pulses |
US8617073B2 (en) | 2009-04-17 | 2013-12-31 | Insightec Ltd. | Focusing ultrasound into the brain through the skull by utilizing both longitudinal and shear waves |
AU2010315132A1 (en) * | 2009-11-04 | 2012-05-31 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Devices and methods for modulating brain activity |
US9694213B2 (en) * | 2009-12-31 | 2017-07-04 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Acoustic coupling for assessment and ablation procedures |
US8932237B2 (en) | 2010-04-28 | 2015-01-13 | Insightec, Ltd. | Efficient ultrasound focusing |
EP2768385B1 (en) | 2011-10-21 | 2021-03-31 | Cerevast Medical, Inc. | System for direct communication |
WO2014036170A1 (en) | 2012-08-29 | 2014-03-06 | Thync, Inc. | Systems and devices for coupling ultrasound energy to a body |
US20140194740A1 (en) * | 2013-01-07 | 2014-07-10 | Cerebrosonics, Llc | Emboli detection in the brain using a transcranial doppler photoacoustic device capable of vasculature and perfusion measurement |
JP2014168603A (ja) * | 2013-03-05 | 2014-09-18 | Jikei Univ | 超音波栓子検出装置 |
WO2015027164A1 (en) | 2013-08-22 | 2015-02-26 | The Regents Of The University Of Michigan | Histotripsy using very short ultrasound pulses |
JP5963811B2 (ja) * | 2014-07-18 | 2016-08-03 | オリンパス株式会社 | 治療用超音波振動子 |
CN113286552A (zh) | 2018-11-28 | 2021-08-20 | 希斯托索尼克斯公司 | 组织摧毁术系统及方法 |
US11716577B2 (en) | 2019-08-15 | 2023-08-01 | Cybersonics, Inc. | Ultrasound transducer and housing for same |
WO2021041797A1 (en) * | 2019-08-30 | 2021-03-04 | Cybersonics, Inc. | Ultrasonic generator and controller for ultrasonic generator |
WO2021155026A1 (en) | 2020-01-28 | 2021-08-05 | The Regents Of The University Of Michigan | Systems and methods for histotripsy immunosensitization |
WO2022221649A1 (en) * | 2021-04-15 | 2022-10-20 | The Regents Of The University Of Michigan | Design and fabrication of therapeutic ultrasound transducer with arbitrarily shaped, densely packing, removable modular elements |
CN113171156B (zh) * | 2021-04-23 | 2022-09-06 | 北京荷清和创医疗科技有限公司 | 植入式医疗器械的超声除栓配件 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08131454A (ja) * | 1994-09-17 | 1996-05-28 | Toshiba Corp | 超音波治療装置および超音波照射装置 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03151952A (ja) | 1989-11-08 | 1991-06-28 | Matsushita Electric Ind Co Ltd | 超音波治療装置 |
JP3300419B2 (ja) | 1991-08-21 | 2002-07-08 | 株式会社東芝 | 血栓溶解治療装置 |
US5307816A (en) * | 1991-08-21 | 1994-05-03 | Kabushiki Kaisha Toshiba | Thrombus resolving treatment apparatus |
EP0659387B1 (en) * | 1993-12-24 | 2003-04-16 | Olympus Optical Co., Ltd. | Ultrasonic diagnosis and therapy system in which focusing point of therapeutic ultrasonic wave is locked at predetermined position within observation ultrasonic scanning range |
US5560362A (en) * | 1994-06-13 | 1996-10-01 | Acuson Corporation | Active thermal control of ultrasound transducers |
US5694936A (en) * | 1994-09-17 | 1997-12-09 | Kabushiki Kaisha Toshiba | Ultrasonic apparatus for thermotherapy with variable frequency for suppressing cavitation |
US5984881A (en) * | 1995-03-31 | 1999-11-16 | Kabushiki Kaisha Toshiba | Ultrasound therapeutic apparatus using a therapeutic ultrasonic wave source and an ultrasonic probe |
US5558092A (en) * | 1995-06-06 | 1996-09-24 | Imarx Pharmaceutical Corp. | Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously |
DE19635593C1 (de) * | 1996-09-02 | 1998-04-23 | Siemens Ag | Ultraschallwandler für den diagnostischen und therapeutischen Einsatz |
US5938612A (en) * | 1997-05-05 | 1999-08-17 | Creare Inc. | Multilayer ultrasonic transducer array including very thin layer of transducer elements |
US6425867B1 (en) * | 1998-09-18 | 2002-07-30 | University Of Washington | Noise-free real time ultrasonic imaging of a treatment site undergoing high intensity focused ultrasound therapy |
US6635017B1 (en) * | 2000-02-09 | 2003-10-21 | Spentech, Inc. | Method and apparatus combining diagnostic ultrasound with therapeutic ultrasound to enhance thrombolysis |
US6537224B2 (en) * | 2001-06-08 | 2003-03-25 | Vermon | Multi-purpose ultrasonic slotted array transducer |
-
2004
- 2004-01-29 US US10/543,916 patent/US7662098B2/en not_active Expired - Fee Related
- 2004-01-29 EP EP04706363A patent/EP1591073A4/en not_active Withdrawn
- 2004-01-29 WO PCT/JP2004/000812 patent/WO2004066856A1/ja active Application Filing
- 2004-01-29 JP JP2005504740A patent/JP4543430B2/ja not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08131454A (ja) * | 1994-09-17 | 1996-05-28 | Toshiba Corp | 超音波治療装置および超音波照射装置 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1591073A4 * |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006137484A1 (ja) * | 2005-06-22 | 2006-12-28 | Hitachi Medical Corporation | 超音波治療装置 |
JP4913736B2 (ja) * | 2005-06-22 | 2012-04-11 | 学校法人慈恵大学 | 超音波治療装置 |
US8740797B2 (en) | 2005-06-22 | 2014-06-03 | The Jikei University | Ultrasonic therapeutic apparatus |
EP1912749B1 (en) * | 2005-07-26 | 2021-04-21 | Surf Technology AS | Dual frequency band ultrasound transducer arrays |
JP2010500084A (ja) * | 2006-08-11 | 2010-01-07 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 脳血流画像化、及びマイクロバブルを用いた血餅溶解をする超音波システム |
JP2010500085A (ja) * | 2006-08-11 | 2010-01-07 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 脳血流撮影及び微細気泡改善血栓消散のための超音波システム |
JP2014000431A (ja) * | 2006-08-11 | 2014-01-09 | Koninklijke Philips Nv | 脳血流画像化、及びマイクロバブルを用いた血餅溶解をする超音波システム |
JP5282309B2 (ja) * | 2007-11-26 | 2013-09-04 | コニカミノルタ株式会社 | 超音波探触子および該製造方法ならびに超音波診断装置 |
US8531178B2 (en) | 2007-11-26 | 2013-09-10 | Konica Minolta Medical & Graphic, Inc. | Ultrasound probe, method for manufacturing the same, and ultrasound diagnostic apparatus |
JP5222942B2 (ja) * | 2008-05-16 | 2013-06-26 | 株式会社日立メディコ | 超音波診断装置 |
JP2012509126A (ja) * | 2008-11-19 | 2012-04-19 | インサイテック・リミテッド | 閉ループ血塊溶解 |
US9177543B2 (en) | 2009-08-26 | 2015-11-03 | Insightec Ltd. | Asymmetric ultrasound phased-array transducer for dynamic beam steering to ablate tissues in MRI |
US9412357B2 (en) | 2009-10-14 | 2016-08-09 | Insightec Ltd. | Mapping ultrasound transducers |
US9852727B2 (en) | 2010-04-28 | 2017-12-26 | Insightec, Ltd. | Multi-segment ultrasound transducers |
JP2014523263A (ja) * | 2011-05-20 | 2014-09-11 | ドヘニー アイ インスティテュート | 眼球用超音波プローブ |
JP2015519970A (ja) * | 2012-06-13 | 2015-07-16 | ニューウェル, デイビッド ダブリュー.NEWELL, David, W. | 超音波血栓溶解療法を用いたクモ膜下血腫の治療、並びに関連する装置、システム、及び方法 |
US9808653B2 (en) | 2012-06-13 | 2017-11-07 | David W. Newell | Treatment of subarachnoid hematoma using sonothrombolysis and associated devices, systems and methods |
US9956431B2 (en) | 2015-03-06 | 2018-05-01 | Murakumo Corporation | Ultrasonic oscillator |
WO2016143016A1 (ja) | 2015-03-06 | 2016-09-15 | 株式会社Murakumo | 超音波発振装置 |
JP5892639B1 (ja) * | 2015-03-06 | 2016-03-23 | 株式会社Murakumo | 超音波発振装置 |
JP2019524294A (ja) * | 2016-08-01 | 2019-09-05 | コーダンス メディカル インコーポレイテッドCordance Medical Inc. | 血液脳関門の超音波ガイド下開放 |
JP7063882B2 (ja) | 2016-08-01 | 2022-05-09 | コーダンス メディカル インコーポレイテッド | 血液脳関門の超音波ガイド下開放 |
JP2022097547A (ja) * | 2016-08-01 | 2022-06-30 | コーダンス メディカル インコーポレイテッド | 血液脳関門の超音波ガイド下開放 |
US11534630B2 (en) | 2016-08-01 | 2022-12-27 | Cordance Medical Inc. | Ultrasound guided opening of blood-brain barrier |
US11857812B2 (en) | 2016-08-01 | 2024-01-02 | Cordance Medical Inc. | Ultrasound guided opening of blood-brain barrier |
JP7531542B2 (ja) | 2016-08-01 | 2024-08-09 | コーダンス メディカル インコーポレイテッド | 血液脳関門の超音波ガイド下開放 |
Also Published As
Publication number | Publication date |
---|---|
JP4543430B2 (ja) | 2010-09-15 |
EP1591073A4 (en) | 2010-11-17 |
JPWO2004066856A1 (ja) | 2006-05-18 |
US20060173321A1 (en) | 2006-08-03 |
EP1591073A1 (en) | 2005-11-02 |
US7662098B2 (en) | 2010-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4543430B2 (ja) | 超音波プローブ及び超音波装置 | |
JP5451819B2 (ja) | 凝血塊を溶解するために組み合わされたイメージング及び治療トランスデューサを使用する方法 | |
Sokka et al. | MRI-guided gas bubble enhanced ultrasound heating in in vivo rabbit thigh | |
US6984209B2 (en) | Harmonic motion imaging | |
EP1790384A1 (en) | Contrast agent augmented ultrasound therapy system with ultrasound imaging guidance for thrombus treatment | |
US9630028B2 (en) | Ultrasound system for cerebral blood flow imaging and microbubble-enhanced blood clot lysis | |
Maleke et al. | Harmonic motion imaging for focused ultrasound (HMIFU): a fully integrated technique for sonication and monitoring of thermal ablation in tissues | |
US20220314034A1 (en) | Systems and methods for high intensity focused ultrasound | |
JP4618810B2 (ja) | 剪断モード診断用超音波 | |
JP4629034B2 (ja) | 剪断モード治療用超音波 | |
JPH03251240A (ja) | 超音波治療装置 | |
JP2009505769A (ja) | 治療トランスデューサ増幅器を有する、画像化及び治療トランスデューサの組合せ | |
JP2007160093A (ja) | 高強度焦点超音波システム及び高強度焦点超音波システム用結合ヘッド | |
WO2011092683A1 (en) | Non-invasive ultrasound treatment of subcostal lesions | |
JP2009505768A (ja) | 複合撮像及び治療トランスデューサ | |
JP4263575B2 (ja) | 超音波送波器及びこれを用いた超音波装置 | |
CN100356895C (zh) | 超声波探针以及超声波装置 | |
US20090264798A1 (en) | System and method for controlling energy delivery using local harmonic motion | |
JP4387947B2 (ja) | 超音波治療装置 | |
JP3145084B2 (ja) | 超音波治療装置 | |
Newman et al. | Design of an Array Transducer for Localizing Microbubble Activity Through the Skull | |
JP3142535B2 (ja) | 超音波治療装置 | |
JP2015156885A (ja) | 超音波治療システム | |
JP2002209895A (ja) | 超音波撮像方法及び超音波撮像装置 | |
Worthington et al. | A comparison of imaging modalities to monitor thermal and mechanical ultrasound tissue therapies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004706363 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005504740 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 2006173321 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10543916 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20048033442 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2004706363 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10543916 Country of ref document: US |